Aurobindo Pharma informs about board meeting

30 Jan 2026 Evaluate

Aurobindo Pharma has informed pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that a Meeting of the Board of Directors of the Company will be held on Monday, February 9, 2026, to consider and approve, the Standalone & Consolidated Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31, 2025. Further to its letter dated December 24, 2025 whereby the company has informed the closure of Trading Window of the Company from January 1, 2026 until 48 hours from the date of declaration of the Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31, 2025, the company has informed that the Trading Window will remain closed up to February 11, 2026 and shall be re-opened on February 12, 2026.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1212.30 61.75 (5.37%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×